Enter assignee name

Forward Citations = 4,674

Loading Chart...

7 inventors (with patents filed for the assignee):

Denise R Barbut (49 out of 94 patents)

Jon St Germain (9 out of 42 patents)

Peter Trexler Keith (6 out of 163 patents)

4. Steven Wayne Berhow (5 out of 13 patents)

5. Russel H Patterson (4 out of 5 patents)

6. Mark-Hein Heinemann (3 out of 4 patents)

7. Joel R Munsinger (2 out of 21 patents)

49 patents: Sort by Forward Citations

1. 8221383 - Devices and methods for preventing distal embolization from the vertebrobasilar artery using flow reversal (2012-07-17),

2. 8137374 - Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature (2012-03-20),

3. 8034043 - Devices and methods for preventing distal embolization using flow reversal by partial occlusion of the brachiocephalic artery (2011-10-11),

4. 7993324 - Cerebral perfusion augmentation (2011-08-09),

5. 7927268 - Counterpulsation device with increased volume-displacement efficiency and methods of use (2011-04-19),

6. 7867195 - Partial aortic occlusion devices and methods for cerebral perfusion augmentation (2011-01-11),

7. 7635376 - Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature (2009-12-22),

8. 7468027 - Partial aortic occlusion devices and methods for cerebral perfusion augmentation (2008-12-23),

9. 7458980 - Devices and methods for preventing distal embolization using flow reversal in arteries having collateral blood flow (2008-12-02),

10. 7452352 - Methods for preventing distal embolization from the vertebrobasilar artery using flow reversal (2008-11-18),

11. 7374561 - Devices and methods for preventing distal embolization during interventional procedures (2008-05-20),

12. 7340298 - Enhancement of cerebral blood flow by electrical nerve stimulation (2008-03-04),

13. 7166097 - Cerebral perfusion augmentation (2007-01-23),

14. 7150736 - Cerebral perfusion augmentation (2006-12-19),

15. 6942686 - Regulation of cerebral blood flow by temperature change-induced vasodilatation (2005-09-13),

CoAxia, Inc. is a medical device company focused on developing and commercializing innovative products for ischemic stroke treatment. Their mission is to improve patient outcomes by providing cutting-edge solutions to healthcare professionals. With a team of dedicated experts, CoAxia aims to revolutionize stroke care through advanced technologies and therapies. Visit their website to learn more about their groundbreaking solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

49 Patents

#6 in Maple Grove, MN

#196 in Minnesota

#6,907 in US

#13,842 in the World

Maple Grove, MN, United States of America

Coaxia, Inc.